Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Hemasphere|November 15, 2019
Chimeric Antigen Receptor-T Cell Therapy: Practical Considerations for Implementation in EuropeJochen Buechner, Marie José Kersten, Miriam Fuchs, et al.
EMBO Reports|July 9, 2002
Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6Jörg Storre, Hans-Peter Elsässer, Miriam Fuchs, et al.
Molecular and Cellular Biology|May 4, 2004
E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1Stefan Taubert, Chiara Gorrini, Scott R Frank, et al.
EMBO Reports|May 31, 2003
MYC recruits the TIP60 histone acetyltransferase complex to chromatinScott R Frank, Tiziana Parisi, Stefan Taubert, et al.
The Journal of Biological Chemistry|March 3, 2005
p400 is required for E1A to promote apoptosisAndrew V Samuelson, Masako Narita, Ho-Man Chan, et al.
Current Hematologic Malignancy Reports|January 23, 2019
Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) ImmunotherapyStacie Ittershagen, Solveig Ericson, Lamis Eldjerou, et al.
Future Oncology (London, England)|June 18, 2024
End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?Evgeny Degtyarev, Natacha Bolaños, Joshua D Brody, et al.
Cytotherapy|April 7, 2024
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related productsMark D Stewart, Michael Kalos, Vicki Coutinho, et al.
Pageof 1